Fragment-based methods for drug optimization have great potential; however, time, expense and sensitivity considerations associated with NMR and x-ray crystallographic based methods limit their applicability. As an alternative we have developed a computational approach, SILCS: Site Identification by Ligand Competitive Saturation, that uses explicit solvent all-atom molecular dynamics to identify binding sites on protein surfaces for functional groups. Information from the SILCS approach may then be combined with structural information on an inhibitorprotein complex to facilitate modification of the ligand to improve its binding affinity. An overview of SILCS and its application to inhibitor-ligand optimization will be presented. Karplus at Harvard University. In 2006, Dr. MacKerell was named the Maryland Chemist of the Year by the ACS Maryland Section for "his numerous scientific achievements, including pioneering research on the aldehyde dehydrogenase enzyme system, biophysical studies, including time-resolved fluorescence, chemical relaxation and MD simulations of ribonuclease T1, developing methodology in the area of empirical force fields and MD simulations, structure-activity relationships of DNA and RNA and the application of computational methods to drug discovery." (Quoted from http://mdchem.org/cc/cc-06-Dec.pdf)
